- cafead   Mar 21, 2024 at 11:22: AM
via The Centers for Medicare and Medicaid Services is highly likely to negotiate the price for Novo Nordisk’s obesity therapy Wegovy (semaglutide) in the coming years, according to a Wednesday report from the Congressional Budget Office.
article source
article source